Neuroscience Researcher

Clinatec, biomedical research center Edmond J. Safra has been working for several years to develop innovative technological solutions for neurodegenerative diseases. Professors Benabid and Mitrofanis have initiated and developed the use of photobiomodulation in preclinical animal models of Parkinson’s disease with the use of an intracranial implant. This method is currently in clinical trial, under the direction of Professor Stephan Chabardès at the University Hospital in Grenoble.

The benefits of photobiomodulation are multiple and its use can be extended to other disease models, including Alzheimer’s disease, the subject of the COVEA NEUROTEC project initiated in 2021 at the CLINATEC Endowment Fund and supervised by Professor John Mitrofanis, scientific director of FDD. Other pathologies and disease models being explored include postmyocardial infarction recovery, autism, traumatic brain injury and quality of sleep. The Clinatec FDD wishes to recruit a researcher with the ability and expertise to set-up and manage new projects, as well as to coordinate current developments and the various researchers.  The appointee will conduct his project research under Professor John Mitrofanis direction and will be the key link between the post-doctoral staff and Professor John Mitrofanis.The development of relationships with institutional partners is also an area to be amplified in relation to photobiomodulation. 

The applicant must have a PhD in the fields of neuroscience, neurobiology or biotechnology. He/she must have previous experience in setting up pre-clinical or clinical projects and coordinating interdisciplinary teams. Experience in the field of photobiomodulation and/or in the general field of photonics is very much desired.

The applicant must be motivated, autonomous, organised and comfortable in a multidisciplinary environment. 

He/she must have between 5 and 10 years of professional experience in the world of research.